{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:50:26Z","timestamp":1761749426673,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.path.2021.11.006","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T05:31:41Z","timestamp":1643607101000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Atypical Ductal Hyperplasia-Ductal Carcinoma In Situ Spectrum: Diagnostic Considerations and Treatment Impact in the Era of Deescalation"],"prefix":"10.1016","volume":"15","author":[{"given":"Melinda E.","family":"Sanders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna B.","family":"Podoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.path.2021.11.006_bib1","first-page":"438","article-title":"Breast cancer statistics, 2019","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"10.1016\/j.path.2021.11.006_bib2","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/jnci\/djt256","article-title":"Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?","volume":"105","author":"Punglia","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.path.2021.11.006_bib3","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/cncr.20979","article-title":"Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study","volume":"103","author":"Collins","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.path.2021.11.006_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","article-title":"The natural history of ductal carcinoma in situ of the breast: a review","volume":"97","author":"Erbas","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.path.2021.11.006_bib5","first-page":"223","article-title":"Long-term follow-up of in situ carcinoma of the breast","volume":"11","author":"Eusebi","year":"1994","journal-title":"Semin Diagn Pathol"},{"issue":"4 Suppl","key":"10.1016\/j.path.2021.11.006_bib6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/1097-0142(19800815)46:4+<919::AID-CNCR2820461311>3.0.CO;2-Z","article-title":"The clinical significance of pre-invasive breast carcinoma","volume":"46","author":"Rosen","year":"1980","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.path.2021.11.006_bib7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/modpathol.2014.141","article-title":"Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up","volume":"28","author":"Sanders","year":"2015","journal-title":"Mod Pathol"},{"issue":"20","key":"10.1016\/j.path.2021.11.006_bib8","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1200\/JCO.19.02888","article-title":"De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer","volume":"38","author":"Hwang","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.path.2021.11.006_bib9","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.20.00124","article-title":"De-Escalating Treatment of Low-Risk Breast Ductal Carcinoma In Situ","volume":"38","author":"Lazzeroni","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.path.2021.11.006_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.path.2021.11.006_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/djq099","article-title":"The heterogeneity of cancer","volume":"102","author":"Welch","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.path.2021.11.006_bib12","series-title":"Ductal carcinoma in situ. WHO Classification of Tumours","first-page":"76","author":"Pinder","year":"2019"},{"issue":"Suppl 1","key":"10.1016\/j.path.2021.11.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41379-020-00665-x","article-title":"Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy","volume":"34","author":"Schnitt","year":"2021","journal-title":"Mod Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.path.2021.11.006_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.breast.2017.06.018","article-title":"De-escalating and escalating surgery in the management of early breast cancer","volume":"34","author":"Morrow","year":"2017","journal-title":"Breast"},{"issue":"7","key":"10.1016\/j.path.2021.11.006_bib15","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jamaoncol.2020.0819","article-title":"De-Escalating Breast Cancer Surgery for Low-Risk Ductal Carcinoma in Situ-Reply","volume":"6","author":"Morrow","year":"2020","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.path.2021.11.006_bib16","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/bcr2128","article-title":"Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer","volume":"10","author":"Tamimi","year":"2008","journal-title":"Breast Cancer Res"},{"issue":"11","key":"10.1016\/j.path.2021.11.006_bib17","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","article-title":"Atypical hyperplastic lesions of the female breast. A long-term follow-up study","volume":"55","author":"Page","year":"1985","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.path.2021.11.006_bib18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cncr.22408","article-title":"Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study","volume":"109","author":"Collins","year":"2007","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.path.2021.11.006_bib19","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1200\/JCO.2006.09.0217","article-title":"Stratification of breast cancer risk in women with atypia: a Mayo cohort study","volume":"25","author":"Degnim","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.path.2021.11.006_bib20","first-page":"1053","article-title":"Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists","volume":"122","author":"Fitzgibbons","year":"1998","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.path.2021.11.006_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.path.2021.11.006_bib22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jama.1992.03480070057030","article-title":"A\u00a0prospective study of benign breast disease and the risk of breast cancer","volume":"267","author":"London","year":"1992","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.path.2021.11.006_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast--risk assessment and management options","volume":"372","author":"Hartmann","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.path.2021.11.006_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1940-6207.CAPR-13-0222","article-title":"Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study","volume":"7","author":"Hartmann","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"10.1016\/j.path.2021.11.006_bib25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y","article-title":"Intraductal carcinoma of the breast: follow-up after biopsy only","volume":"49","author":"Page","year":"1982","journal-title":"Cancer"},{"year":"2019","author":"Fitzgibbons","series-title":"Protocol for the examination of biopsy specimens from patients with invasive carcinoma of the breast","key":"10.1016\/j.path.2021.11.006_bib26"},{"issue":"3","key":"10.1016\/j.path.2021.11.006_bib27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/1097-0142(19900201)65:3<518::AID-CNCR2820650324>3.0.CO;2-O","article-title":"A\u00a0comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast","volume":"65","author":"Tavassoli","year":"1990","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.path.2021.11.006_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.6004\/jnccn.2021.0023","article-title":"NCCN Guidelines(R) Insights: Breast Cancer, Version 4.2021","volume":"19","author":"Gradishar","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.path.2021.11.006_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11912-019-0777-3","article-title":"Management of Ductal Carcinoma In Situ (DCIS) of the Breast: Present Approaches and Future Directions","volume":"21","author":"Solin","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.path.2021.11.006_bib30","series-title":"WHO Classification of Tumours","first-page":"18","article-title":"Atypical ductal hyperplasia","author":"Allison","year":"2019"},{"issue":"5","key":"10.1016\/j.path.2021.11.006_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s40291-020-00482-7","article-title":"Oncotype DX Breast Recurrence Score((R)): A Review of its Use in Early-Stage Breast Cancer","volume":"24","author":"Syed","year":"2020","journal-title":"Mol Diagn Ther"},{"issue":"4","key":"10.1016\/j.path.2021.11.006_bib32","first-page":"320","article-title":"[Validation and clinical application of MammaPrint((R)) in patients with breast cancer]","volume":"85","author":"Sanchez-Forgach","year":"2017","journal-title":"Cir Cir"},{"key":"10.1016\/j.path.2021.11.006_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13058-015-0586-z","article-title":"Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast","volume":"17","author":"Pang","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.path.2021.11.006_bib34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2018.06.027","article-title":"Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project","volume":"101","author":"Thompson","year":"2018","journal-title":"Eur J Cancer"},{"issue":"23","key":"10.1016\/j.path.2021.11.006_bib35","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-18-0842","article-title":"A\u00a0Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk","volume":"24","author":"Bremer","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.path.2021.11.006_bib36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-015-3464-6","article-title":"A\u00a0population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone","volume":"152","author":"Rakovitch","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.path.2021.11.006_bib37","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A\u00a0multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.path.2021.11.006_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-018-4693-2","article-title":"Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies","volume":"169","author":"Rakovitch","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"10.1016\/j.path.2021.11.006_bib39","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1158\/1078-0432.CCR-19-1152","article-title":"Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy","volume":"26","author":"Weinmann","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.path.2021.11.006_bib40","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/modpathol.2016.127","article-title":"Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review","volume":"29","author":"Mooney","year":"2016","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2021.11.006_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-017-4253-1","article-title":"Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia","volume":"164","author":"Pena","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.path.2021.11.006_bib42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12282-018-00943-2","article-title":"Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens","volume":"26","author":"Rageth","year":"2019","journal-title":"Breast Cancer"},{"issue":"6","key":"10.1016\/j.path.2021.11.006_bib43","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/PAS.0b013e31828ba25c","article-title":"Borderline atypical ductal hyperplasia\/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively","volume":"37","author":"Vandenbussche","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2021.11.006_bib44","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.acra.2018.09.010","article-title":"Radiologic and Pathologic Features Associated With Upgrade of Atypical Ductal Hyperplasia at Surgical Excision","volume":"26","author":"Williams","year":"2019","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.path.2021.11.006_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archsurg.1989.01410010035007","article-title":"Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment","volume":"124","author":"Schwartz","year":"1989","journal-title":"Arch Surg"},{"issue":"2","key":"10.1016\/j.path.2021.11.006_bib46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.2009.169","article-title":"Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study","volume":"23","author":"Castellano","year":"2010","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.path.2021.11.006_bib47","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/00000478-200108000-00005","article-title":"Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting","volume":"25","author":"Ely","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2021.11.006_bib48","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00000478-200606000-00001","article-title":"An analysis of breast cancer risk in women with single, multiple, and atypical papilloma","volume":"30","author":"Lewis","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2021.11.006_bib49","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00428-003-0888-x","article-title":"Central atypical papillomas of the breast: a clinicopathological study of 119 cases","volume":"443","author":"MacGrogan","year":"2003","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.path.2021.11.006_bib50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<258::AID-CNCR11>3.0.CO;2-V","article-title":"Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma","volume":"78","author":"Page","year":"1996","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/j.path.2021.11.006_bib51","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1245\/s10434-016-5596-2","article-title":"Active Surveillance for DCIS: The Importance of Selection Criteria and Monitoring","volume":"23","author":"Grimm","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.path.2021.11.006_bib52","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1245\/s10434-017-5927-y","article-title":"A\u00a0Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease","volume":"24","author":"Jakub","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.path.2021.11.006_bib53","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2214\/AJR.17.19244","article-title":"Patient Selection for Ductal Carcinoma In Situ Observation Trials: Are the Lesions Truly Low Risk?","volume":"211","author":"Patel","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.path.2021.11.006_bib54","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1245\/s10434-016-5268-2","article-title":"Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?","volume":"23","author":"Pilewskie","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.path.2021.11.006_bib55","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"33","key":"10.1016\/j.path.2021.11.006_bib56","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study","volume":"33","author":"Solin","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2021.11.006_bib57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-013-2813-6","article-title":"Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS)","volume":"143","author":"Wong","year":"2014","journal-title":"Breast Cancer Res Treat"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918121000933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918121000933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:42:32Z","timestamp":1761748952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918121000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1875918121000933"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2021.11.006","relation":{},"ISSN":["1875-9181"],"issn-type":[{"type":"print","value":"1875-9181"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical Ductal Hyperplasia-Ductal Carcinoma In Situ Spectrum: Diagnostic Considerations and Treatment Impact in the Era of Deescalation","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2021.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}